T cell experts at Kiadis bag CytoSen's NK cell tech, plotting a dual cancer killing approach with tips from Carl June
In an effort to marry T cell and natural killer cell technologies for the treatment of blood cancer, Dutch biotech Kiadis has inked an all …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
